IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 156 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $43,000 | +152.9% | 4,200 | +145.8% | 0.01% | +33.3% |
| Q1 2020 | $17,000 | -93.2% | 1,709 | -90.9% | 0.01% | -81.6% |
| Q4 2019 | $250,000 | +8.7% | 18,800 | -29.9% | 0.05% | -18.3% |
| Q3 2019 | $230,000 | +103.5% | 26,835 | +159.7% | 0.06% | +81.8% |
| Q2 2019 | $113,000 | -40.5% | 10,335 | -31.1% | 0.03% | +32.0% |
| Q1 2019 | $190,000 | +9400.0% | 15,000 | +14900.0% | 0.02% | – |
| Q1 2018 | $2,000 | -98.3% | 100 | -98.8% | 0.00% | -100.0% |
| Q4 2017 | $121,000 | -63.0% | 8,101 | -53.2% | 0.03% | -43.8% |
| Q2 2017 | $327,000 | +91.2% | 17,314 | +54.6% | 0.05% | +118.2% |
| Q4 2016 | $171,000 | -2.3% | 11,200 | +2.2% | 0.02% | -31.2% |
| Q1 2015 | $175,000 | – | 10,962 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |